LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027

Market By Therapeutic Application, Product, Analysis Purpose, End-user, Analysis Platform, Biomarker Type, Clinical Application And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the liquid biopsy market in Latin America is expected to proliferate with a CAGR of 26.60% in the forecast period of 2019-2027.

The countries that have been considered in the report on Latin America’s liquid biopsy market are:

•           Brazil

•           Mexico

•           Rest of Latin America

A trend that is related to precision medicine is the emergence of tissue/tumour-agnostic drugs, which target specific genetic variants within cancer and drive the use of liquid biopsy diagnostics for detecting these variations. The expanded approval of Merck’s drug, Keytruda in May 2017 for use in patients with metastatic cancer and those who have microsatellite instability or mismatch repair deficiency was the first instance of this phenomenon. Other drug companies are now pursuing the same approval strategy, which emphasizes the genetic feature of cancer rather than the organ of origin.

Report scope can be customized per your requirements. Request For Customization

However, the absence of reimbursement can abridge the adoption of liquid biopsy. The reimbursement & treatment monitoring for liquid biopsy is insufficient, and few laboratories perform these procedures. The average cost of liquid biopsy is around $925, and the reimbursement provided for it is around $300-$435. The reimbursement coverage depends on the type of cancer, early or late screening procedure and the type of therapy selected for it. A liquid biopsy is a new technology in the market, which is highly adopted in developed countries. However, in developing countries, though there is an immense market opportunity, this technology is not much adopted. In developing countries, a tissue biopsy is mostly preferred than liquid biopsy. In such countries, the companies and laboratories need to convince the physicians about the liquid biopsy. Further, lack of reimbursement and awareness about liquid biopsy can decline its adoption, which can impact the market growth negatively.

B. Braun Melsungen AG is a leading healthcare company that supplies products for intensive care, anaesthesia, cardiology, surgery and extracorporeal blood treatment. It also offers healthcare services to general practitioners, hospitals and the homecare sector. B. Braun operates in the Asia-Pacific, the Middle East, Africa, Europe, Latin America and North America. The company’s comprehensive product & service portfolio is providing it with a leadership position in the market. B. Braun’s presence in diverse markets helps it reduce its dependency risk. Strategic acquisitions are likely to help the company expand its footprint in the market.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA LIQUID BIOPSY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTES

2.3.3.   BARGAINING POWER OF BUYERS

2.3.4.   BARGAINING POWER OF SUPPLIERS

2.3.5.   THREAT OF RIVALRY

2.4. REGULATORY FRAMEWORK

2.5. KEY MARKET TRENDS

2.6. KEY LIQUID BIOPSY INITIATIVES

2.7. MARKET ATTRACTIVENESS INDEX

2.8. MARKET DRIVERS

2.8.1.   CANCER CASES IN OLDER POPULACE ARE SIGNIFICANTLY INCREASING

2.8.2.   DIAGNOSTIC CENTERS ARE IN DEMAND

2.8.3.   TISSUE/TUMOR-AGNOSTIC DRUGS USAGE ARE INCREASING

2.8.4.   RISE IN USAGE OF PRECISION MEDICINE

2.9. MARKET RESTRAINTS

2.9.1.   HIGH COST OF TEST

2.9.2.   LACK OF A CONSENSUS ON STANDARD OPERATING PROCEDURES (SOPs)

2.10.            MARKET OPPORTUNITIES

2.10.1.                ADVANCEMENT IN TECHNOLOGY

2.10.2.                RISING NUMBER OF CANCER PATIENTS

2.11.            MARKET CHALLENGES

2.11.1.                LACK OF REIMBURSEMENT

2.11.2.                SKILLED PROFESSIONALS ARE QUITE LESS IN NUMBER

3.    LIQUID BIOPSY MARKET OUTLOOK - BY THERAPEUTIC APPLICATION

3.1. PROSTATE CANCER

3.2. MELANOMA CANCER

3.3. BREAST CANCER

3.4. COLORECTAL CANCER

3.5. LUNG CANCER

3.6. OTHER TYPES OF CANCER

3.7. NON-ONCOLOGY APPLICATIONS

4.    LIQUID BIOPSY MARKET OUTLOOK - BY PRODUCT

4.1. CELL-FREE DNA (CFDNA)

4.2. CIRCULATING TUMOR CELLS (CTCS)

4.3. CIRCULATING TUMOR DNA (CTDNA)

4.4. EXTRACELLULAR VESICLES AND OTHERS

5.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PURPOSE

5.1. MONITORING

5.2. THERAPY GUIDANCE

5.3. EARLY DETECTION/SCREENING

5.4. DIAGNOSIS

6.    LIQUID BIOPSY MARKET OUTLOOK - BY END-USER

6.1. HOSPITALS

6.2. PHYSICIANS’ OFFICE LABORATORIES

6.3. CLINICAL DIAGNOSTIC LABORATORIES

7.    LIQUID BIOPSY MARKET OUTLOOK - BY ANALYSIS PLATFORM

7.1. MICROARRAY

7.2. NGS

7.3. PROTEOMICS

7.4. PCR

7.5. OTHER ANALYSIS PLATFORMS

8.    LIQUID BIOPSY MARKET OUTLOOK - BY BIOMARKER TYPE

8.1. NUCLEIC ACIDS

8.2. PROTEINS

8.3. EXTRACELLULAR VESICLES

8.4. CELLS

9.    LIQUID BIOPSY MARKET OUTLOOK - BY CLINICAL APPLICATION

9.1. TREATMENT MONITORING

9.2. PROGNOSIS & REOCCURRENCE MONITORING

9.3. TREATMENT SELECTION

9.4. DIAGNOSIS & SCREENING

10. LIQUID BIOPSY MARKET - REGIONAL OUTLOOK

10.1.            LATIN AMERICA

10.2.            COUNTRY ANALYSIS

10.2.1.1.   BRAZIL

10.2.1.2.   MEXICO

10.2.1.3.   REST OF LATIN AMERICA

11. COMPETITIVE LANDSCAPE

11.1.            AGILENT TECHNOLOGIES, INC.

11.2.            BOSTON SCIENTIFIC CORPORATION

11.3.            ARGON MEDICAL DEVICES, INC.

11.4.            B. BRAUN MELSUNGEN AG

11.5.            CINTEC MEDICAL LTD.

11.6.            ROCHE DIAGNOSTICS CORPORATION

11.7.            AD-TECH MEDICAL INSTRUMENT CORP.

11.8.            I.M.S. INTERNAZIONALE MEDICO SCIENTIFICA SRL

11.9.            QIAGEN N.V.

11.10.         BECTON, DICKINSON

11.11.         PLANMECA OY

11.12.         BIO-RAD LABORATORIES, INC.

11.13.         CARDINAL HEALTH, INC.

11.14.         COOK MEDICAL, INC.

11.15.         FISCHER MEDICAL TECHNOLOGIES LLC

11.16.         C. R. BARD, INC. (ACQUIRED BY BECTON, DICKINSON AND COMPANY)

12. RESEARCH METHODOLOGY & SCOPE

12.1.            RESEARCH SCOPE & DELIVERABLES

12.1.1.                OBJECTIVES OF STUDY

12.1.2.                SCOPE OF STUDY

12.2.            SOURCES OF DATA

12.2.1.                PRIMARY DATA SOURCES

12.2.2.                SECONDARY DATA SOURCES

12.3.            RESEARCH METHODOLOGY

12.3.1.                EVALUATION OF PROPOSED MARKET

12.3.2.                IDENTIFICATION OF DATA SOURCES

12.3.3.                ASSESSMENT OF MARKET DETERMINANTS

12.3.4.                DATA COLLECTION

12.3.5.                DATA VALIDATION & ANALYSIS

List of table

TABLE 1        LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

TABLE 2        LIQUID BIOPSY BIOMARKER CLASSES

TABLE 3        LATIN AMERICA LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)

TABLE 4        LATIN AMERICA LIQUID BIOPSY MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 5        LATIN AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PURPOSE 2019-2027 ($ MILLION)

TABLE 6        LATIN AMERICA LIQUID BIOPSY MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 7        LATIN AMERICA LIQUID BIOPSY MARKET BY ANALYSIS PLATFORM 2019-2027 ($ MILLION)

TABLE 8        ADVANTAGES OF DROPLET DIGITAL PCR FOR SINGLE-CELL ANALYSIS

TABLE 9        DROPLET DIGITAL PCR INDUSTRIES

TABLE 10      LATIN AMERICA LIQUID BIOPSY MARKET BY BIOMARKER TYPE 2019-2027 ($ MILLION)

TABLE 11      CELL DIFFERENTIATORS

TABLE 12      LATIN AMERICA LIQUID BIOPSY MARKET BY CLINICAL APPLICATION 2019-2027 ($ MILLION)

TABLE 13      LATIN AMERICA BIOPSY MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 2      LATIN AMERICA LIQUID BIOPSY MARKET BY PROSTATE CANCER 2019-2027 ($ MILLION)

FIGURE 3      LATIN AMERICA LIQUID BIOPSY MARKET BY MELANOMA CANCER 2019-2027 ($ MILLION)

FIGURE 4      TYPES OF BREAST CANCER

FIGURE 5      LATIN AMERICA LIQUID BIOPSY MARKET BY BREAST CANCER 2019-2027 ($ MILLION)

FIGURE 6      LATIN AMERICA LIQUID BIOPSY MARKET BY COLORECTAL CANCER 2019-2027 ($ MILLION)

FIGURE 7      LATIN AMERICA LIQUID BIOPSY MARKET BY LUNG CANCER 2019-2027 ($ MILLION)

FIGURE 8      LATIN AMERICA LIQUID BIOPSY MARKET BY OTHER TYPES OF CANCER 2019-2027 ($ MILLION)

FIGURE 9      LATIN AMERICA LIQUID BIOPSY MARKET BY NON-ONCOLOGY APPLICATION 2019-2027 ($ MILLION)

FIGURE 10   LATIN AMERICA LIQUID BIOPSY MARKET BY CELL-FREE DNA (CFDNA) 2019-2027 ($ MILLION)

FIGURE 11   LATIN AMERICA LIQUID BIOPSY MARKET BY CIRCULATING TUMOR CELLS (CTCS) 2019-2027 ($ MILLION)

FIGURE 12   LATIN AMERICA LIQUID BIOPSY MARKET BY CIRCULATING TUMOR DNA (CTDNA) 2019-2027 ($ MILLION)

FIGURE 13   LATIN AMERICA LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES AND OTHERS 2019-2027 ($ MILLION)

FIGURE 14   LATIN AMERICA LIQUID BIOPSY MARKET BY MONITORING 2019-2027 ($ MILLION)

FIGURE 15   LATIN AMERICA LIQUID BIOPSY MARKET BY THERAPY GUIDANCE 2019-2027 ($ MILLION)

FIGURE 16   LATIN AMERICA LIQUID BIOPSY MARKET BY EARLY DETECTION/SCREENING 2019-2027 ($ MILLION)

FIGURE 17   LATIN AMERICA LIQUID BIOPSY MARKET BY DIAGNOSIS 2019-2027 ($ MILLION)

FIGURE 18   LATIN AMERICA LIQUID BIOPSY MARKET BY HOSPITALS 2019-2027 ($ MILLION)

FIGURE 19   LATIN AMERICA LIQUID BIOPSY MARKET BY PHYSICIANS’ OFFICE LABORATORIES 2019-2027 ($ MILLION)

FIGURE 20   LATIN AMERICA LIQUID BIOPSY MARKET BY CLINICAL DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 21   LATIN AMERICA LIQUID BIOPSY MARKET BY MICROARRAY 2019-2027 ($ MILLION)

FIGURE 22   LATIN AMERICA LIQUID BIOPSY MARKET BY NGS 2019-2027 ($ MILLION)

FIGURE 23   LATIN AMERICA LIQUID BIOPSY MARKET BY PROTEOMICS 2019-2027 ($ MILLION)

FIGURE 24   LATIN AMERICA LIQUID BIOPSY MARKET BY PCR 2019-2027 ($ MILLION)

FIGURE 25   LATIN AMERICA LIQUID BIOPSY MARKET BY OTHER ANALYSIS PLATFORM 2019-2027 ($ MILLION)

FIGURE 26   LATIN AMERICA LIQUID BIOPSY MARKET BY NUCLEIC ACIDS 2019-2027 ($ MILLION)

FIGURE 27   LATIN AMERICA LIQUID BIOPSY MARKET BY PROTEINS 2019-2027 ($ MILLION)

FIGURE 28   LATIN AMERICA LIQUID BIOPSY MARKET BY EXTRACELLULAR VESICLES 2019-2027 ($ MILLION)

FIGURE 29   LATIN AMERICA LIQUID BIOPSY MARKET BY CELLS 2019-2027 ($ MILLION)

FIGURE 30   LATIN AMERICA LIQUID BIOPSY MARKET BY TREATMENT MONITORING 2019-2027 ($ MILLION)

FIGURE 31   LATIN AMERICA LIQUID BIOPSY MARKET BY PROGNOSIS & REOCCURRENCE MONITORING 2019-2027 ($ MILLION)

FIGURE 32   LATIN AMERICA LIQUID BIOPSY MARKET BY TREATMENT SELECTION 2019-2027 ($ MILLION)

FIGURE 33   LATIN AMERICA LIQUID BIOPSY MARKET BY DIAGNOSIS & SCREENING 2019-2027 ($ MILLION)

FIGURE 34   LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 35   BRAZIL LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 36   MEXICO LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

FIGURE 37   REST OF LATIN AMERICA LIQUID BIOPSY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;